11.2.4 Pfizer Inc. 11.2.5 Novartis
List of Tables: Table 8-1: Global- Biologic Erythropoietin Drugs and Their Sales Table 10-1: Global- Erythropoietin Product Pipeline Table 11-1: Amgen Inc.- Total Company Revenue( Billion US $), 2013, 2014 & 2015 Table 11-2: Amgen Inc.- Commercialized Erythropoietin Products Table 11-3: Amgen Inc.- Erythropoietin Product Sales( Billion US $), 2013, 2014 & 2015 Table 11-4: Johnson & Johnson- Total Company Sales( Billion US $), 2013, 2014 & 2015 Table 11-5: Johnson & Johnson- Commercialized Erythropoietin Products
Browse Full Report With TOC @ http:// www. radiantinsights. com / research / epobiosimilars-the-future-of-erythropoietin-market
Table 11-6: Johnson & Johnson- Erythropoietin Product Sales( Billion US $), 2013, 2014 & 2015 Table 11-7: Roche- Total Company Revenue( Billion US $), 2013, 2014 & 2015 Table 11-8: Roche- Commercialized Erythropoietin Products Table 11-9: Roche- Erythropoietin Product Sales( Billion US $), 2013, 2014 & 2015 Table 11-10: Pfizer Inc.- Total Company Revenue( Billion US $), 2013, 2014 & 2015 Table 11-11: Pfizer Inc.- Commercialized Erythropoietin Products Table 11-12: Novartis- Total Company Sales( Billion US $), 2013, 2014 & 2015 Table 11-13: Novartis- Commercialized Erythropoietin Products
List of Figures:
Figure 3-1: Global- Population above 60 Years( Billion), 2013 & 2050
Figure 3-2: Global- Incidences of Cancer( Million), 2015 & 2025
Follow Us: